240 related articles for article (PubMed ID: 17493279)
21. Cerebral phaeohyphomycosis in an immunodeficient child treated medically with combination antifungal therapy.
Trinh JV; Steinbach WJ; Schell WA; Kurtzberg J; Giles SS; Perfect JR
Med Mycol; 2003 Aug; 41(4):339-45. PubMed ID: 12964727
[TBL] [Abstract][Full Text] [Related]
22. New antifungal drugs and new clinical trials: interpreting results may be difficult.
Girmenia C; Martino P
Curr Opin Oncol; 2003 Jul; 15(4):283-8. PubMed ID: 12874505
[TBL] [Abstract][Full Text] [Related]
23. Successful treatment of invasive aspergillosis with oral voriconazole following intravenous liposomal amphotericin in a child with acute lymphoblastic leukemia.
Lassaletta A; Perez A; Díaz MA; Sevilla J; González-Vicent M; Madero L
J Pediatr Hematol Oncol; 2004 Feb; 26(2):117-9. PubMed ID: 14767202
[No Abstract] [Full Text] [Related]
24. Successful voriconazole therapy of disseminated Fusarium solani in the brain of a neutropenic cancer patient.
Vincent AL; Cabrero JE; Greene JN; Sandin RL
Cancer Control; 2003; 10(5):414-9. PubMed ID: 14581897
[No Abstract] [Full Text] [Related]
25. Fatal Scopulariopsis brevicaulis infection in a paediatric stem-cell transplant patient treated with voriconazole and caspofungin and a review of Scopulariopsis infections in immunocompromised patients.
Steinbach WJ; Schell WA; Miller JL; Perfect JR; Martin PL
J Infect; 2004 Jan; 48(1):112-6. PubMed ID: 14667801
[No Abstract] [Full Text] [Related]
26. Resolution of orbitocerebral aspergillosis during combination treatment with voriconazole and amphotericin plus adjunctive cytokine therapy.
Bethell D; Hall G; Goodman TR; Klein N; Pollard AJ
J Pediatr Hematol Oncol; 2004 May; 26(5):304-7. PubMed ID: 15111783
[TBL] [Abstract][Full Text] [Related]
27. Resolution of fungemia due to Fusarium species in a patient with acute leukemia treated with caspofungin.
Apostolidis J; Bouzani M; Platsouka E; Belasiotou H; Stamouli M; Harhalakis N; Boutati EI; Paniara O; Nikiforakis E
Clin Infect Dis; 2003 May; 36(10):1349-50. PubMed ID: 12746788
[No Abstract] [Full Text] [Related]
28. Voriconazole treatment of presumptive disseminated Aspergillus infection in a child with acute leukemia.
Shouldice E; Fernandez C; McCully B; Schmidt M; Fraser R; Cook C
J Pediatr Hematol Oncol; 2003 Sep; 25(9):732-4. PubMed ID: 12972810
[TBL] [Abstract][Full Text] [Related]
29. Successful treatment of Acremonium fungemia with voriconazole.
Mattei D; Mordini N; Lo Nigro C; Gallamini A; Osenda M; Pugno F; Viscoli C
Mycoses; 2003 Dec; 46(11-12):511-4. PubMed ID: 14641626
[TBL] [Abstract][Full Text] [Related]
30. Successful treatment of disseminated Fusarium infection in an immunocompromised child.
Barrios NJ; Kirkpatrick DV; Murciano A; Stine K; Van Dyke RB; Humbert JR
Am J Pediatr Hematol Oncol; 1990; 12(3):319-24. PubMed ID: 2240479
[TBL] [Abstract][Full Text] [Related]
31. Successful elimination of an invasive Aspergillus nidulans lung infection by voriconazole after failure of a combination of caspofungin and liposomal amphotericin B in a boy with chronic granulomatous disease.
Rösen-Wolff A; Koch A; Friedrich W; Hahn G; Gahr M; Roesler J
Pediatr Infect Dis J; 2004 Jun; 23(6):584-6. PubMed ID: 15194848
[TBL] [Abstract][Full Text] [Related]
32. Combination therapy with caspofungin and amphotericin B lipid complex.
Lum LR; Turco TF; Leone J
Am J Health Syst Pharm; 2002 Jan; 59(1):80-1. PubMed ID: 11813474
[No Abstract] [Full Text] [Related]
33. Treatment of Fusarium Infection of the Central Nervous System: A Review of Past Cases to Guide Therapy for the Ongoing 2023 Outbreak in the United States and Mexico.
Hoenigl M; Jenks JD; Egger M; Nucci M; Thompson GR
Mycopathologia; 2023 Dec; 188(6):973-981. PubMed ID: 37653167
[TBL] [Abstract][Full Text] [Related]
34. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B.
Eljaschewitsch J; Sandfort J; Tintelnot K; Horbach I; Ruf B
Mycoses; 1996; 39(3-4):115-9. PubMed ID: 8767004
[TBL] [Abstract][Full Text] [Related]
35. Case report and review of resolved fusariosis.
Helm TN; Longworth DL; Hall GS; Bolwell BJ; Fernandez B; Tomecki KJ
J Am Acad Dermatol; 1990 Aug; 23(2 Pt 2):393-8. PubMed ID: 2203833
[TBL] [Abstract][Full Text] [Related]
36. Systemic Fusarium nygamai infection in a patient with lymphoblastic non-Hodgkin's lymphoma.
Krulder JW; Brimicombe RW; Wijermans PW; Gams W
Mycoses; 1996; 39(3-4):121-3. PubMed ID: 8767005
[TBL] [Abstract][Full Text] [Related]
37. Combined antifungal treatment of visceral mucormycosis with caspofungin and liposomal amphotericin B.
Voitl P; Scheibenpflug C; Weber T; Janata O; Rokitansky AM
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):632-4. PubMed ID: 12226700
[No Abstract] [Full Text] [Related]
38. Disseminated visceral fusariosis treated with amphotericin B-phospholipid complex.
Engelhard D; Eldor A; Polacheck I; Hardan I; Ben-Yehuda D; Amselem S; Salkin IF; Lopez-Berestein G; Sacks T; Rachmilewitz EA
Leuk Lymphoma; 1993 Mar; 9(4-5):385-92. PubMed ID: 8348074
[TBL] [Abstract][Full Text] [Related]
39. [A silver lining on the horizon: new antimycotics].
Schäfer-Korting M; Holzgrabe U
Pharm Unserer Zeit; 2003; 32(2):154-6. PubMed ID: 12677969
[No Abstract] [Full Text] [Related]
40. Successful treatment of ocular invasive mould infection (fusariosis) with the new antifungal agent voriconazole.
Reis A; Sundmacher R; Tintelnot K; Agostini H; Jensen HE; Althaus C
Br J Ophthalmol; 2000 Aug; 84(8):932-3. PubMed ID: 10979655
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
